ONALI, SARA
 Distribuzione geografica
Continente #
NA - Nord America 2.799
EU - Europa 334
AS - Asia 200
SA - Sud America 3
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 3.338
Nazione #
US - Stati Uniti d'America 2.799
SG - Singapore 113
IT - Italia 66
IE - Irlanda 61
CN - Cina 59
DE - Germania 38
SE - Svezia 32
UA - Ucraina 30
RU - Federazione Russa 27
FI - Finlandia 23
GB - Regno Unito 21
BE - Belgio 17
KR - Corea 10
FR - Francia 9
ID - Indonesia 4
JP - Giappone 4
VN - Vietnam 4
AT - Austria 2
BR - Brasile 2
CZ - Repubblica Ceca 2
HR - Croazia 2
IN - India 2
NL - Olanda 2
AU - Australia 1
ES - Italia 1
EU - Europa 1
IR - Iran 1
KW - Kuwait 1
LT - Lituania 1
PE - Perù 1
PH - Filippine 1
TR - Turchia 1
Totale 3.338
Città #
Wilmington 781
Houston 677
Woodbridge 486
Chandler 137
Ann Arbor 120
Fairfield 111
Singapore 103
Ashburn 57
Seattle 54
Dublin 44
Cambridge 36
Medford 36
Rome 32
Santa Clara 28
Dearborn 26
Jacksonville 19
Brussels 17
Helsinki 17
Lawrence 17
New York 14
Beijing 13
Palo Alto 10
Redwood City 8
San Diego 7
Council Bluffs 5
Seoul 5
Cagliari 4
Jakarta 4
Menlo Park 4
Munich 4
Dong Ket 3
Nanjing 3
New Bedfont 3
Norwalk 3
Verona 3
Wuhan 3
Zhengzhou 3
Creede 2
Jinan 2
Kilburn 2
Kunming 2
La Veta 2
London 2
Mainz 2
Milan 2
Moscow 2
Scorzè 2
Vienna 2
Yellow Springs 2
Alba 1
Altopascio 1
Americana 1
Amsterdam 1
Ankara 1
Baoding 1
Baotou 1
Boardman 1
Brno 1
Changsha 1
Chengdu 1
Chicago 1
Collegeville 1
Crévic 1
Cupertino 1
Delhi 1
Espoo 1
Falls Church 1
Fuzhou 1
Guangzhou 1
Hanoi 1
Hefei 1
Hokkaido 1
Hounslow 1
Islington 1
Kuwait City 1
Lima 1
Los Angeles 1
Makati 1
Miami Beach 1
Milazzo 1
Mountain View 1
Mülheim 1
Nanchang 1
Olomouc 1
Osaka 1
Padova 1
Parma 1
Phoenix 1
Pune 1
Quzhou 1
Saint Petersburg 1
San Francisco 1
Sant'agata De' Goti 1
Shenyang 1
Southwark 1
Sydney 1
Tokyo 1
University Park 1
Vilnius 1
Xian 1
Totale 2.972
Nome #
Cancer and immunomodulators in inflammatory bowel diseases 445
Psoriasis Phenotype in Inflammatory Bowel Disease: A Case-Control Prospective Study 434
Impact of a multidisciplinary approach in enteropathic spondyloarthritis patients 432
Mongersen, an oral SMAD7 antisense oligonucleotide, and crohn's disease 369
Comparative Efficacy of Vedolizumab and Adalimumab in Ulcerative Colitis Patients Previously Treated With Infliximab 266
Use of synthetic and biological DMARDs in patients with enteropathic spondyloarthritis: a combined gastro-rheumatological approach 226
Tbet Expression in Regulatory T Cells Is Required to Initiate Th1-Mediated Colitis 194
Development of a numerical index quantitating small bowel damage as detected by ultrasonography in Crohn's disease 164
Intention-to-treat survival benefit of liver transplantation in patients with hepatocellular cancer 163
Response assessed by Ultrasonography as Target of Biological Treatment for Crohn's disease: Treat to target in CD using Ultrasonography 129
The Intention-to-Treat Effect of Bridging Treatments in the Setting of Milan Criteria–In Patients Waiting for Liver Transplantation 114
Postoperative Crohn's disease recurrence as assessed by conventional vs alternative non invasive techniques 112
A Novel Smad7 Genetic Variant Mapping on the Genomic Region Targeted by Mongersen Is Associated with Crohn's Disease 87
Post-operative recurrence of Crohn's disease: A prospective study at 5 years 56
null 42
A pharmacological batch of Mongersen that downregulates Smad7 is effective as induction therapy in active Crohn's disease: a phase II, open-label study 42
The Resolution of intestinal inflammation: the peace-keeper's perspective 40
Azathioprine for prevention of clinical recurrence in Crohn's disease patients with severe endoscopic recurrence: an IG-IBD randomized double-blind trial 40
Response assessed by ultrasonography as target of biological treatment for Crohn's disease 31
Charting the Path Forward for Risk Prediction in Liver Transplant for Hepatocellular Carcinoma: International Validation of HALTHCC Among 4,089 Patients 27
A phase 1 open-label trial shows that smad7 antisense oligonucleotide (GED0301) does not increase the risk of small bowel strictures in Crohn{'}s disease 11
Suboptimal disease control and contributing factors in Italian IBD patients: The IBD-PODCAST Study 8
Prognostic Factors for 10-Year Survival in Patients With Hepatocellular Cancer Receiving Liver Transplantation 2
Pragmatic Trial Design to Compare Real-world Effectiveness of Different Treatments for Inflammatory Bowel Diseases: The PRACTICE-IBD European Consensus 2
SARS-CoV-2 infection in patients with inflammatory bowel disease: comparison between the first and second pandemic waves 1
Safety of treatments for inflammatory bowel disease: Clinical practice guidelines of the Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD) 1
Therapies for inflammatory bowel disease do not pose additional risks for adverse outcomes of SARS-CoV-2 infection: an IG-IBD study. 1
null 1
Totale 3.440
Categoria #
all - tutte 9.333
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.333


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020616 0 0 0 0 0 95 80 88 95 91 85 82
2020/2021874 85 76 96 100 99 102 119 110 24 30 27 6
2021/2022253 9 25 9 26 27 11 18 6 29 25 19 49
2022/2023284 27 43 8 42 32 53 14 22 30 2 7 4
2023/202474 17 5 12 1 7 18 2 5 0 1 0 6
2024/2025293 16 85 77 76 7 32 0 0 0 0 0 0
Totale 3.440